CD8A and cholangiocarcinoma: Considering the complexity of the tumor microenvironment, and tumor heterogeneity, it is possible that PD-L1 expression should be combined with another marker such as CD8+ T cells infiltration, Treg cells or TAMs expression in order to gain more insights into their prognostic values in CCA patients.